IDH1 and astrocytoma (excluding glioblastoma): In the current WHO 2021 classification, IDH1/2-mutant gliomas are further classified into those with a 1p/19q codeletion (oligodendrogliomas grade 2–3) and those without (astrocytomas grade 2–4).